Established in 1985, COC Farmaceutici is an Italian Contract Manufacturing (CMO) for medical devices and pharmaceutical products mainly in the ophthalmic market. COC Farmaceutici has a unique competitive positioning in the arena of the contract manufacturers, being among the few European CMOs dedicated to liquid and quasi-liquid formats. The Company is the one-stop-shop, from laboratory to shelf for its customers, who are mainly well-known Italian pharmaceutical groups.
Founded in 1941, Tubilux Pharma is one of the top Italian players active in the research, development and manufacturing (CDMO) of pharmaceutical ophthalmic products for blue-chip international pharmaceutical companies. The company has a specific focus on R&D and operates with a dedicated team, composed by more than 20 people working on several projects for European and US customers. Manufacturing activities are carried out in the proprietary production facility of about 7,700 sqm in compliance with current Good Manufacturing Practices (GMP), authorized by AIFA (Agenzia Italiana del Farmaco) and approved by FDA (Food and Drug Administration).
The integration between COC Farmaceutici and Tubilux Pharma enables the creation of the first leading group in the Italian market and a relevant European CDMO in the ophthalmic and other liquids. With three production facilities of which two authorized by AIFA and one also FDA approved, 17 production lines and more than 500 employees, the Group is able to further consolidate its competitive positioning in the reference market.